#2 Rushnet Inc (OTCMKTS: RSHN) is a sleeping that is making a powerhouse run up the charts in recent days as the Company drops big on its recently acquired by Ashley Sweat. So far, 2nd Quarter is proving to be yet another record quarter for heliosDX. In the 1st Quarter of 2021, heliosDX generated a record $1,252,000 in revenue. This was a new company benchmark. In April and May 2021, heliosDX has generated revenues totaling approximately $990,000 respectively. This is an average of $495,000 a month. This also includes another record of approximately $530,000 in revenue for the month of May. This growth puts heliosdDX on pace to hit their stretch projected 2nd quarter target of $1.4 to $1.5 million. This again sets another company benchmark. This would equate to just over a 20% revenue growth quarter over quarter. heliosDX enjoyed a 70%+ revenue growth from 2019 to 2020, and to see the growth continue speaks volumes to the execution of the plan, and the staff at heliosDX.
Rushnet Inc has been around for years selling edibles and beverage based company with stand-alone products, including most enhanced with CBD. Recentlly they aquired HeliosDx and Chattahoochee Labs which has been around since 2006 and has generated well over 6 million dollars in revenue in 2021.This year we take on our third mass spectrometer, the powerful Absciex 4500, which will allow us to serve the massive needs of our clientele, which has been under strain.With the procurementof a new QuantStudio 12x we now have the ability to test 1500 Covid19 patients per day. With infectious disease testing validations being completed next week, we will be able to better serve clients all over by creating more robust testing menus and quicker turnaround time for Covid19, UTI, and RPP testing. Furthermore, with the assumption of our Ion S5 GeneStudio NGS testing equipment, we are poised for the huge genetics market that is so underserved
heliosDX has had a delay in launching their Infectious Disease platform in-house. However, heliosDX does continue to realize revenue from this platform by referencing out tests. That said, the original revenue growth target for Q2 included revenue from launching infectious disease as an in-house testing platform. The good news, heliosDX will still achieve our quarter 2 revenue targets. In addition, we are about a week out from launching the platform in-house realizing even more revenue and testing volume growth. There has been a change in the verbiage from RushNet, Inc acquiring heliosDX, to RushNet, Inc being acquired by Ashley Sweat. Ashley Sweat currently serves as the Chairman and CEO of RushNet. Inc. He also is the Owner and CEO of heliosDX. The plan has been and continues to be to reverse merge heliosDX into RushNet, Inc. As mentioned previously, this is a very fluid process, and thus there have been structural changes to the Purchase Agreement to ensure long-term success of this transaction, and the company in general moving forward.
Some key events being worked on by the Company include: Filing Disclosures Imminent, Filing Financials Imminent, Attorney Letter Coming, Mid Quarter Financial update and Highlights Released. Pink Current Coming, Audit Financials In Process, Website transition chattahoocheelabs.com to heliosDX.com – Near Completion, Professional Sales and Marketing Video In Progress. Spin Off RushNet, Inc Subsidiaries, Acquisition(s) and/or LOI Update, Complete the Reverse Merger, R/S Reassessment, Reengage FINRA. SEC Reporting
News 
Market Data 
Discover 
